Replies to post #455637 on Anavex Life Sciences Corp (AVXL)

[BAR123]

So not knowing the corporate response to your question, but I would suggest that it is such a small market that they’re better off going first to EMA and FDA, and then head to some of the outlying countries. Why spend their valuable resources on something that won’t net them nearly as much as Europe or the US will. Also, I wouldn’t be surprised if Australia excepts FDA and EMA approvals.